Furthermore, inhibition of NOX4 in HGSOC cells led to decreases in VEGF levels, HIF-1 levels, and tumor angiogenesis
The clinical trials have shown that SGLT-2i reduced NPDR progression in T2DM patients with hypertension, likely due to its anti-inflammatory and hemodynamic effects (104, 105)
PABA/NO and JS-K demonstrated antitumor activity in mice bearing human ovarian carcinoma (Findlay et al., 2004) and prostate carcinoma (Laschak et al., 2012) or multiple myeloma (Kiziltepe et al., 2007), respectively
By circumventing the stomach and digestive tract, the patient can also avoid such side effects
Additionally, it has been associated with resistance to ionizing radiation and drug-induced cytotoxicity